Literature DB >> 26164003

Pokemon and MEF2D co-operationally promote invasion of hepatocellular carcinoma.

Xin Hong1, Xing-Yu Hong1, Tao Li2, Cheng-Yan He3.   

Abstract

Hepatocellular carcinoma (HCC) is one of the most deadly human malignancy, and frequent invasion and metastasis is closely associated with its poor prognosis. However, the molecular mechanism underlying HCC invasion is still not completely elucidated. Pokemon is a well-established oncogene for HCC growth, but its contribution to HCC invasion has not been studied yet. In this paper, Pokemon was found to be overexpressed in MHCC-97H HCC cell line, which possesses higher invasiveness. Downregulation of Pokemon abolished the invasion of MHCC-97H HCC cell lines. Pokemon overexpression was able to enhance the invasion of MHCC-97L cells with lower invasiveness. MEF2D, an oncogene promoting the invasion of HCC cells, was further detected to be upregulated and downregulated when Pokemon was overexpressed and silenced, respectively. Online database analysis indicated that one Pokemon recognition site was located within the promoter of MEF2D. Chromatin co-precipitation, luciferase, and qPCR assays all proved that Pokemon can promote the expression of MEF2D in HCC cells. Restoration of MEF2D expression can prevent the impaired invasion of HCC cells with Pokemon silencing, while suppression of MEF2D abolished the effect of Pokemon overexpression on HCC invasion. More interestingly, MEF2D was also found to increase the transcription of Pokemon by binding myocyte enhancer factor 2 (MEF2) sites within its promoter region, implying an auto-regulatory circuit consisting of these two oncogenes that can promote HCC invasion. Our findings can contribute to the understanding of molecular mechanism underlying HCC invasion, and provided evidence that targeting this molecular loop may be a promising strategy for anti-invasion therapy.

Entities:  

Keywords:  Hepatocellular carcinoma; Invasion; MEF2D; Pokemon

Mesh:

Substances:

Year:  2015        PMID: 26164003     DOI: 10.1007/s13277-015-3744-0

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  12 in total

1.  Overexpression of the transcription factor MEF2D in hepatocellular carcinoma sustains malignant character by suppressing G2-M transition genes.

Authors:  Leina Ma; Jia Liu; Limei Liu; Guangjie Duan; Qingliang Wang; Yanmin Xu; Feng Xia; Juanjuan Shan; Junjie Shen; Zhi Yang; Ping Bie; Youhong Cui; Xiu-Wu Bian; Jesus Prieto; Matías A Avila; Cheng Qian
Journal:  Cancer Res       Date:  2014-01-03       Impact factor: 12.701

2.  Knockdown of Pokemon protein expression inhibits hepatocellular carcinoma cell proliferation by suppression of AKT activity.

Authors:  Xiaosan Zhu; Yichen Dai; Zhangxin Chen; Junpei Xie; Wei Zeng; Yuanyuan Lin
Journal:  Oncol Res       Date:  2013       Impact factor: 5.574

3.  Depletion of Pokemon gene inhibits hepatocellular carcinoma cell growth through inhibition of H-ras.

Authors:  Quan-Le Zhang; De-An Tian; Xiang-Jiang Xu
Journal:  Onkologie       Date:  2011-09-23

4.  A biomimetic nanovector-mediated targeted cholesterol-conjugated siRNA delivery for tumor gene therapy.

Authors:  Yang Ding; Wei Wang; Meiqing Feng; Yu Wang; Jianping Zhou; Xuefang Ding; Xin Zhou; Congyan Liu; Ruoning Wang; Qiang Zhang
Journal:  Biomaterials       Date:  2012-09-12       Impact factor: 12.479

5.  MEF2 transcription factors promotes EMT and invasiveness of hepatocellular carcinoma through TGF-β1 autoregulation circuitry.

Authors:  Wei Yu; Changshan Huang; Qian Wang; Tao Huang; Yuechao Ding; Chao Ma; Hongbo Ma; Weiyu Chen
Journal:  Tumour Biol       Date:  2014-08-03

6.  Pokemon silencing leads to Bim-mediated anoikis of human hepatoma cell QGY7703.

Authors:  Kun Liu; Feng Liu; Nannan Zhang; Shiying Liu; Yuyang Jiang
Journal:  Int J Mol Sci       Date:  2012-05-15       Impact factor: 6.208

7.  New human hepatocellular carcinoma (HCC) cell line with highly metastatic potential (MHCC97) and its expressions of the factors associated with metastasis.

Authors:  J Tian; Z Y Tang; S L Ye; Y K Liu; Z Y Lin; J Chen; Q Xue
Journal:  Br J Cancer       Date:  1999-11       Impact factor: 7.640

8.  miR-96/HBP1/Wnt/β-catenin regulatory circuitry promotes glioma growth.

Authors:  Zhiyong Yan; Jianpeng Wang; Chao Wang; Yingbing Jiao; Weiguo Qi; Shusheng Che
Journal:  FEBS Lett       Date:  2014-06-12       Impact factor: 4.124

9.  The silencing of Pokemon attenuates the proliferation of hepatocellular carcinoma cells in vitro and in vivo by inhibiting the PI3K/Akt pathway.

Authors:  Chan-Chan Lin; Jing-Ping Zhou; Yun-Peng Liu; Jing-Jing Liu; Xiao-Ning Yang; Amarsanaa Jazag; Zhi-Ping Zhang; Bayasi Guleng; Jian-Lin Ren
Journal:  PLoS One       Date:  2012-12-26       Impact factor: 3.240

10.  Silencing of Pokemon enhances caspase-dependent apoptosis via fas- and mitochondria-mediated pathways in hepatocellular carcinoma cells.

Authors:  Yu-Qin Zhang; Chuan-Xing Xiao; Bi-Yun Lin; Ying Shi; Yun-Peng Liu; Jing-Jing Liu; Bayasi Guleng; Jian-Lin Ren
Journal:  PLoS One       Date:  2013-07-17       Impact factor: 3.240

View more
  5 in total

1.  Absent expression of miR-30a promotes the growth of lung cancer cells by targeting MEF2D.

Authors:  Nianxu Luan; Yi Wang; Xuedong Liu
Journal:  Oncol Lett       Date:  2018-05-16       Impact factor: 2.967

Review 2.  Role of ZBTB7A zinc finger in tumorigenesis and metastasis.

Authors:  Atul Kumar Singh; Shiv Verma; Prem Prakash Kushwaha; Kumari Sunita Prajapati; Mohd Shuaib; Shashank Kumar; Sanjay Gupta
Journal:  Mol Biol Rep       Date:  2021-05-20       Impact factor: 2.316

3.  DYRK1A phosphorylates MEF2D and decreases its transcriptional activity.

Authors:  Pin Wang; Juan Zhao; Xiulian Sun
Journal:  J Cell Mol Med       Date:  2021-06-09       Impact factor: 5.310

Review 4.  MEF2 signaling and human diseases.

Authors:  Xiao Chen; Bing Gao; Murugavel Ponnusamy; Zhijuan Lin; Jia Liu
Journal:  Oncotarget       Date:  2017-12-04

Review 5.  The multi-faceted functioning portrait of LRF/ZBTB7A.

Authors:  Caterina Constantinou; Magda Spella; Vasiliki Chondrou; George P Patrinos; Adamantia Papachatzopoulou; Argyro Sgourou
Journal:  Hum Genomics       Date:  2019-12-10       Impact factor: 4.639

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.